Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GUANFACINE HYDROCHLORIDE
- Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
- A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder
- Treatment With Cannabis Oil Containing CBD Only or 20:1 CBD:THC vs. Placebo of Persons With ADHD
- Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study
- The Effect of Guanfacine on Delirium in Critically Ill Patients
- Combining Varenicline and Guanfacine for Smoking Cessation
- The BIomarker Guided Study for Depression
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
- Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
- Guanfacine to Improve Substance Use Outcomes in Women
- Efficacy of Guanfacine and Lidocaine Combination in Trigeminal Nerve Block for Pain Management in Trigeminal Neuropathy
- Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
- Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
- Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents
- Guanfacine Extended Release and Mindfulness Skills Therapy
- Noradrenergic Add-on Therapy With Guanfacine
- Guanfacine for PONV and Pain After Sinus Surgery
- The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
- CRT-Guanfacine for SPD
- Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers
- An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
- Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
- Does Guanfacine Attenuate Stress-Induced Drinking?
- Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).
- Guanfacine Clinical Trial for Smoking Cessation
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- PK/PD Comparison of Guanfacine ER and IR
- Open-Trial of EPI-743 for Adults With Tourette Syndrome
- Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
- Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
- The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects
- Guanfacine in Children With Tic Disorders
- Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe
- Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
- Inuniv and Working Memory
- N-acetylcysteine (NAC) for Children With Tourette Syndrome
- Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
- Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
- Interventions for Children With Attention and Reading Disorders
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
- Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
- Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
- Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance
- Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects
- A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
- Modeling Stress-precipitated Smoking Behavior for Medication Development
- Guanfacine Immediate-release Electrocardiogram Results (QTc) Study
- Stress and Medication Effects on Cocaine Cue Reactivity
- Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
- Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
- DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
- DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
- SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms
- Guanfacine to Treat Borderline Personality Disorder
- Pharmacology of Cognition in Schizotypal Personality Disorder
- Treatment of Supine Hypertension in Autonomic Failure
- Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17
- Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
- Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
- Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)
- Hypertension Screening and Treatment Program
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
Clinical trials list
click for details